Advertisement

New evidences recommend an active lifestyle in young HCM patients

      Historically, after the pivotal investigations by BJ Maron, HCM has been considered the number 1 killer in young competitive athletes. Indeed, pioneering pathologic investigations from the Minneapolis Institute Foundation confirmed HCM as the most common substrate for sudden cardiac death (SCD) in young people engaged in vigorous sport activities [
      • Maron B.J.
      • Haas T.S.
      • Murphy C.J.
      • Ahluwalia A.
      • Rutten-Ramos S.
      Incidence and causes of sudden death in U.S. college athletes.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Maron B.J.
        • Haas T.S.
        • Murphy C.J.
        • Ahluwalia A.
        • Rutten-Ramos S.
        Incidence and causes of sudden death in U.S. college athletes.
        J. Am. Coll. Cardiol. 2014 Apr 29; 63 (Epub 2014 Feb 26. PMID: 24583295): 1636-1643https://doi.org/10.1016/j.jacc.2014.01.041
        • Harmon K.G.
        • Asif I.M.
        • Maleszewski J.J.
        • Owens D.S.
        • Prutkin J.M.
        • Salerno J.C.
        • Zigman M.L.
        • Ellenbogen R.
        • Rao A.L.
        • Ackerman M.J.
        • Drezner J.A.
        Incidence, cause, and comparative frequency of sudden cardiac death in National Collegiate Athletic Association Athletes: a decade in review.
        Circulation. 2015 Jul 7; 132 (Epub 2015 May 14. PMID: 25977310; PMCID: PMC4496313): 10-19https://doi.org/10.1161/CIRCULATIONAHA.115.015431
        • Finocchiaro G.
        • Papadakis M.
        • Robertus J.L.
        • Dhutia H.
        • Steriotis A.K.
        • Tome M.
        • Mellor G.
        • Merghani A.
        • Malhotra A.
        • Behr E.
        • Sharma S.
        • Sheppard M.N.
        Etiology of sudden death in sports: insights from a United Kingdom regional registry.
        J. Am. Coll. Cardiol. 2016 May 10; 67 (PMID: 27151341): 2108-2115https://doi.org/10.1016/j.jacc.2016.02.062
        • Maron B.J.
        • Klues H.G.
        Surviving competitive athletics with hypertrophic cardiomyopathy.
        Am. J. Cardiol. 1994 Jun 1; 73 (PMID: 8198037): 1098-1104https://doi.org/10.1016/0002-9149(94)90290-9
        • Pelliccia A.
        • Caselli S.
        • Pelliccia M.
        • Musumeci M.B.
        • Lemme E.
        • Di Paolo F.M.
        • Maestrini V.
        • Russo D.
        • Limite L.
        • Borrazzo C.
        • Autore C.
        Clinical outcomes in adult athletes with hypertrophic cardiomyopathy: a 7-year follow-up study.
        Br. J. Sports Med. 2020 Aug; 54 (Epub 2020 Jun 12. PMID: 32532845): 1008-1012https://doi.org/10.1136/bjsports-2019-100890
        • Dejgaard L.A.
        • Haland T.F.
        • Lie O.H.
        • Ribe M.
        • Bjune T.
        • Leren I.S.
        • Berge K.E.
        • Edvardsen T.
        • Haugaa K.H.
        Vigorous exercise in patients with hypertrophic cardiomyopathy.
        Int. J. Cardiol. 2018 Jan 1; 250 (PMID: 29169752): 157-163https://doi.org/10.1016/j.ijcard.2017.07.015
        • Lampert R.
        • Olshansky B.
        • Heidbuchel H.
        • Lawless C.
        • Saarel E.
        • Ackerman M.
        • Calkins H.
        • Estes N.A.
        • Link M.S.
        • Maron B.J.
        • Marcus F.
        • Scheinman M.
        • Wilkoff B.L.
        • Zipes D.P.
        • Berul C.I.
        • Cheng A.
        • Law I.
        • Loomis M.
        • Barth C.
        • Brandt C.
        • Dziura J.
        • Li F.
        • Cannom D.
        Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry.
        Circulation. 2013 May 21; 127 (PMID: 23690453): 2021-2030https://doi.org/10.1161/CIRCULATIONAHA.112.000447
        • Andreassen Kristine
        • Dejgaard Lars A.
        • Lie Øyvind
        • Fink Trine S.
        • Lunde Ida G.
        • Edvardsen Thor
        • Haugaa Kristina H.
        • Stokke Mathis K.
        Exercise training during childhood and adolescence is associated with favorable diastolic function in hypertrophic cardiomyopathy.
        International Journal of Cardiology. 2022; 364: 65-71https://doi.org/10.1016/j.ijcard.2022.06.042
        • Konhilas J.P.
        • Watson P.A.
        • Maass A.
        • et al.
        Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy.
        Circ. Res. 2006; 98: 540-548https://doi.org/10.1161/01.RES.0000205766.97556.00
        • Sheikh N.
        • Papadakis M.
        • Schnell F.
        • Panoulas V.
        • Malhotra A.
        • Wilson M.
        • Carré F.
        • Sharma S.
        Clinical profile of athletes with hypertrophic cardiomyopathy.
        Circ. Cardiovasc. Imaging. 2015 Jul; 8 (Erratum in: Circ Cardiovasc Imaging. 2015 Sep;8(9):e000010. Erratum in: Circ Cardiovasc Imaging. 2015 Sep;8(9):e000010. PMID: 26198026)e003454https://doi.org/10.1161/CIRCIMAGING.114.003454

      Linked Article

      • Cardiovascular symptom phenotypes of post-acute sequelae of SARS-CoV-2
        International Journal of CardiologyVol. 366
        • Preview
          Acute COVID-19 infection has been shown to have significant effects on the cardiovascular system. Post-acute sequelae of SARS-CoV-2 (PASC) are being identified in patients; however, the cardiovascular effects are yet to be well-defined. The Post-COVID Cardiology Clinic at Washington University evaluates and treats patients with ongoing cardiovascular PASC.
        • Full-Text
        • PDF